CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Evolutionary Genomics, Inc.  (FNAM)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 

Evolutionary Genomics's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

FNAM Gross Margin (Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
Y / Y Revenue Change -72.8 % - - - -
Y / Y Gross Profit Change - - - - -
Gross Margin - - - 52.8 % 44.25 %
Gross Margin Total Ranking # 52 # 612 # 668 # 2174 # 2632
Seq. Revenue Change 124.67 % -36.66 % -26.08 % -74.14 % -
Seq. Gross Profit Change - - - -69.15 % -


Commenting Forth Quarter 2016 Gross Margin
Evolutionary Genomics, Inc. Gross Profit grew by 225.48 % in IV. Quarter sequntially to 0 millions, while Revenue increased by 124.67 %, this led to improvement in Company's Gross Margin to 144.87 % a new company high.

Observing forth quarter 2016 results within Medical Laboratories industry only one other company has achieved higher Gross Margin. While Gross Margin total ranking has impoved so far to 52, from total ranking in previous quarter at 612.
Learn about Gross Margin
FNAM's Gross Margin forth quarter 2016 Company Ranking
Within: No.
Industry # 2
Sector # 4
S&P 500 # 52

Gross Margin Statistics
High Average Low
144.87 % 88.38 % 44.25 %
(Dec 31 2016)   (Dec 31 2015)

You need to upgrade your Flash Player


Financial Statements
Evolutionary Genomics's (Dec 31 2016) Gross Profit $ 0 FNAM's Income Statement
Evolutionary Genomics's (Dec 31 2015) Gross Profit $ 0 Quarterly FNAM's Growth
FNAM's Profits by Division See FNAM's Profits by Segment

Other Gross Margin Profitability Ratios
FNAM's Cumulative Gross Margin
Medical Laboratories Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
FNAM's Gross Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for FNAM's Competitors
Gross Margin Profit Margin for Evolutionary Genomics's Suppliers
Gross Margin Profit Margin for FNAM's Customers

You may also want to know
FNAM's Annual Growth Rates FNAM's Profitability Ratios FNAM's Asset Turnover Ratio FNAM's Dividend Growth
FNAM's Roe FNAM's Valuation Ratios FNAM's Financial Strength Ratios FNAM's Gross Profit Growth
FNAM's Roa FNAM's Inventory Turnover Ratio FNAM's Growth Rates FNAM's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Dec 31 2016, within Medical Laboratories Industry Gross MarginDec 31 2016 MRQ Gross ProfitDec 31 2016 MRQ Revenue
Radnet, Inc.  342.74 %$ 770.959 $ 224.939 
Evolutionary Genomics, Inc.  144.87 %$ 0.104 $ 0.072 
Sorrento Therapeutics, Inc.  106.49 %$ 4.280 $ 4.019 
Senomyx Inc  100.00 %$ 4.202 $ 4.202 
Pieris Pharmaceuticals, Inc.  100.00 %$ 2.726 $ 2.726 
Cleveland Biolabs Inc  100.00 %$ 0.990 $ 0.990 
Arrowhead Research Corp  100.00 %$ 4.365 $ 4.365 
Geovax Labs, Inc.  100.00 %$ 0.175 $ 0.175 
Prolung Inc  100.00 %$ 0.009 $ 0.009 
Exelixis, Inc.  97.61 %$ 75.729 $ 77.581 
Incyte Corp  93.99 %$ 306.888 $ 326.498 
Opgen Inc  89.81 %$ 0.904 $ 1.007 
Intrexon Corp  86.69 %$ 39.879 $ 46.002 
Genomic Health Inc  84.07 %$ 69.562 $ 82.742 
Mynd Analytics, Inc.  83.33 %$ 0.019 $ 0.022 
Caredx, Inc.  75.56 %$ 8.205 $ 10.859 
Cryo Cell International Inc  75.40 %$ 4.427 $ 5.871 
Pressure Biosciences Inc  74.67 %$ 0.313 $ 0.420 
International Stem Cell Corp  73.08 %$ 1.235 $ 1.690 
Veracyte, Inc.  64.32 %$ 11.742 $ 18.257 
Inc Research Holdings, Inc.  61.72 %$ 250.634 $ 406.071 
Psychemedics Corp  59.44 %$ 6.398 $ 10.764 
National Research Corporation  59.22 %$ 17.858 $ 30.156 
Enzo Biochem Inc  57.91 %$ 15.208 $ 26.260 
American Shared Hospital Services  55.87 %$ 2.827 $ 5.060 
Icagen, Inc.  55.38 %$ 3.118 $ 5.629 
Parexel International Corp  42.68 %$ 261.300 $ 612.200 
Foundation Medicine, Inc.  41.93 %$ 12.087 $ 28.824 
Pra Health Sciences, Inc.  41.92 %$ 198.031 $ 472.386 
Cancer Genetics, Inc  40.91 %$ 2.958 $ 7.230 
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
CCCR's Profile
Stock Price
CCCR's Financials
CCCR's Expectations
Business Description
Fundamentals
Charts & Quotes
CCCR's News
Suppliers
CCCR's Competitors
Customers & Markets
Economic Indicators
CCCR's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com